Concepedia

Rachael A. McCloy

RA

Statistics

Publications

19

Citations

1.9K

H-Index

17

Active since

2011

Affiliations

Garvan Institute of Medical Research(Current)

The Kinghorn Cancer Centre

UNSW Sydney

St Vincent's Clinic

Monash University

Rachael A. McCloy is an author at Garvan Institute of Medical Research specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2011–2022

19

Publications

19

Partial inhibition of Cdk1 in G<sub>2</sub>phase overrides the SAC and decouples mitotic events

Rachael A. McCloy, Samuel Rogers, C. Elizabeth Caldon et al. · Cell Cycle · 2014 · 870 citations · Full text

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

Claire Vennin, Venessa Chin, Sean Warren et al. · Science Translational Medicine · 2017 · 262 citations · Full text

Global Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies Novel Substrate Dephosphorylation Motifs

Rachael A. McCloy, Benjamin L. Parker, Samuel Rogers et al. · Molecular & Cellular Proteomics · 2015 · 71 citations · Full text

MASTL overexpression promotes chromosome instability and metastasis in breast cancer

Samuel Rogers, Rachael A. McCloy, Benjamin L. Parker et al. · Oncogene · 2018 · 64 citations · Full text

, , +16

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer

Andrew Stone, Fátima Valdés‐Mora, Julia M.W. Gee et al. · PLoS ONE · 2012 · 62 citations · Full text

, , +18

1–5 of 19